11. COVID Flashcards

1
Q

Coronaviruses

A
  • Coronaviruses = group of viruses
  • Impact: mild respiratory infections such as the common cold
  • Rare forms include severe acute respiratory syndrome (SARS), middle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

COVID 19

A
  • SARS-CoV-2 member of the coronaviruses
  • Incubation period: up to 2 weeks
  • Spread: close contact and respiratory droplets
  • Among the symptomatic, 5% become critically ill: respiratory failure, acute respiratory distress syndrome, sepsis; thromboembolism/multiorgan failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Key dates

A
Late Jan-first case
March-10,000+, Lockdown 1
April-100,000+
October-1M+
December-Lockdown 2, Pfizer vaccine approved 
January-Lockdown 3
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Social distancing/masks

A

+Practical method to reduce reproductive value (RO) of virus since it can spread via airborne respiratory secretions from mouth and nose
-Common good conflicts suppression of personal liberty

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Reproductive value

A

The average number of people an infected individual can pass the virus onto [contagion]
WHO: 2-2.5 in March 2020

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Herd immunity

A

‘The resistance to the spread of a contagious disease within a population that results if a sufficiently high proportion of individuals are immune to the disease, primarily through vaccination [also mass infection]’
60-70%

+Avoid overwhelming our finite healthcare facilities as in Italy
+More proactive than social distancing because, more people will be generating immunity, effective post-lockdown
+Protects vulnerable groups
-Unclear if infection and recovery guarantees full immunity, and if so, for how long
-Initially, only way to develop immunity was mass infection; gambling lives of young and healthy on a 0.3-0.6% infection-fatality rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Lockdown

A

+PHO believe necessary and effective for reducing transmission and saving lives

  • Economic downturn: UK GDP 25% lower in April 2020; 500k businesses reported to be in severe economic hardship in September 2020
  • Mental health
  • Violation of individual rights and freedom
    (1) Transparency: justification for lockdown clearly communicated
    (2) Reciprocity: quarantines must be provided with food, shelter, support, non-discrimination
    (3) Least restrictive: least restrictive setting to achieve goal of quarantine –> Tier –> restrictions on freedom proportionate to pandemic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Ventilators

A
  • SARS-COV-2 is principally a respiratory pathogen; takes over breathing for a patient, giving their body time to fight off the virus
  • 4,000 ventilators, acted to secure 30,000 by September 2020
  • 6.6 critical care beds per 100,000 people vs average 11 in Europe
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

More beds and hospitals

A

(1) Nightingale Hospitals built –> 2 wards and a capacity for 4000 patient s
(2) Non urgent operations cancelled
(3) Increased discharge of patients where safe and practicable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cancer patients (NHS England Cancer Resilience Plan)

A
  • London needs to treat 500+ cancer patients/week but most green sites compromised
  • Only 122 cancer cases treated in London as of recently
  • 3840 priority 2 cancer patients waiting beyond target of 62 days for first treatment –> 4 weeks or risk to life or limb
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Vaccine Clinical Trials

A

-Pre-clinical studies
-Phase 1: major safety concerns
-Phase 2 (100s): generates immune response consistently
-Phase 3 (1000s): safety and efficacy
Phase 4: post marketing surveillance by pharmas or regulatory bodies (MHRA, yellow card scheme)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Regulatory Bodies

A
  • ICH-GCP
  • Declaration of Helsinki
  • EU Clinical Trials Directive
  • RCPCH Guidelines
  • NHS Research Ethics Committee
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

COVID expediated by

A
  • Accumulated knowledge and technology from research on coronaviruses over the last 50 years
  • Funding and resources; £850M invested in Europe, 3/4 COVID research published with open access; collaboration of datasets
  • Regulatory bodies prioritising COVID research
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Types of vaccines

A
  • Pathogen
  • Subunit
  • Nucleic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Vaccine successes

A
  • Polio eradicated in 1980s
  • Smallpox eradicated; mortality rate of 30%
  • Measles and diptheria reduced by 99.9%
  • HPV vaccine caused 90% fall in pre-cancerous cells in vaccinated young women
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pros and cons of vaccines

A

+Reduce reproductive value of disease by reducing transmission and providing immunity
+Practical, safe and effective –> Evidenced Based Research and rigorous clinical trial
+In accordance with regulatory and ethical standards: ICHGCP, Helsinki, NHS Research Ethics Committee
+Post marketing oversight by MHRA and Yellow Card Scheme

  • Side effects (painful; heavy feeling and tenderness in arm; tiredness; headache; mild flu like symptoms)
  • Integrity and scientific base of vaccines has been compromised by misinformation –> vaccine only effective if there is public trust in it
17
Q

Pfizer and BioNTech vaccine

A
  • First RNA vaccine
  • 52%/95% effective
  1. Injecting RNA encoding a modified form of SARS-COV-2s spike protein into the body
  2. Glycoprotein that facilitates virus entry into human cells
  3. RNA instructs host cells to make a spike protein, which the immune system reacts to, producing antibodies and activating T cells
  4. Second dose after 3 weeks to strengthen immune response
  5. Upon reinfection, antibodies and T cells destroy cells expressing spike protein
18
Q

Tests x2

A

(1) Antigen test (NAT)
- Tests for RNA of SARS-COV-2
- Uses a polymerase chain reaction (PCR) by swap sample to detect for RNA
- Reliable in first week; virus disappears from throat and lungs

(2) Antibody test
- Tests exposure by testing for the presence of antibodies (IgM, IgG)
- Acquired some degree of immunity